X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (331) 331
Book Review (53) 53
Conference Proceeding (31) 31
Patent (25) 25
Publication (17) 17
Book / eBook (9) 9
Compact Disc (5) 5
Book Chapter (2) 2
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (169) 169
humans (150) 150
oncology (140) 140
female (84) 84
male (83) 83
aged (77) 77
middle aged (74) 74
chemotherapy (59) 59
cancer (54) 54
colorectal cancer (52) 52
adult (49) 49
care and treatment (41) 41
treatment outcome (38) 38
prognosis (37) 37
colorectal neoplasms - drug therapy (35) 35
metastasis (33) 33
aged, 80 and over (30) 30
bevacizumab (30) 30
colorectal neoplasms - pathology (27) 27
survival (24) 24
retrospective studies (23) 23
tumors (23) 23
therapy (22) 22
1st-line treatment (21) 21
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
double-blind (21) 21
performing operations (21) 21
transporting (21) 21
analysis (20) 20
oxaliplatin (20) 20
adenocarcinoma (19) 19
health aspects (19) 19
risk factors (19) 19
antineoplastic agents - therapeutic use (18) 18
combined operations (18) 18
general tagging of cross-sectional technologies spanning over several sections of the ipc (18) 18
general tagging of new technological developments (18) 18
machine tools (18) 18
mechanical metal-working without essentially removingmaterial (18) 18
metal-working not otherwise provided for (18) 18
other working of metal (18) 18
patients (18) 18
pharmacology & pharmacy (18) 18
punching metal (18) 18
survival analysis (18) 18
technical subjects covered by former uspc (18) 18
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (18) 18
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (18) 18
universal machine tools (18) 18
working or processing of metal wire (18) 18
medicine & public health (17) 17
mutation (17) 17
open-label (17) 17
cancer therapies (16) 16
fluorouracil (16) 16
gastroenterology & hepatology (16) 16
neoplasm staging (16) 16
research (16) 16
review (16) 16
carcinoma (15) 15
gastric cancer (15) 15
metastases (15) 15
phase-iii trial (15) 15
trial (15) 15
angiogenesis inhibitors - therapeutic use (14) 14
animals (14) 14
clinical trials (14) 14
colorectal neoplasms - genetics (14) 14
disease-free survival (14) 14
fluorouracil - administration & dosage (14) 14
breast cancer (13) 13
quality of life (13) 13
adenocarcinoma - drug therapy (12) 12
angiogenesis (12) 12
cell biology (12) 12
deoxycytidine - analogs & derivatives (12) 12
hematology, oncology and palliative medicine (12) 12
italy - epidemiology (12) 12
leucovorin (12) 12
neoplasm metastasis (12) 12
pancreatic cancer (12) 12
antibodies, monoclonal - therapeutic use (11) 11
antineoplastic agents (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
capecitabine (11) 11
diagnosis (11) 11
endothelial growth-factor (11) 11
immunohistochemistry (11) 11
medical prognosis (11) 11
phase-ii trial (11) 11
quality-of-life (11) 11
ramucirumab (11) 11
survival rate (11) 11
antimitotic agents (10) 10
breast-cancer (10) 10
cetuximab (10) 10
colorectal carcinoma (10) 10
fixed constructions (10) 10
follow-up studies (10) 10
gemcitabine (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Modern Pathology, ISSN 0893-3952, 11/2015, Volume 28, Issue 11, pp. 1481 - 1491
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 86, pp. 106 - 114
In 2015, we published a study on a small series of patients with hepatocellular carcinoma (HCC) treated chronically with metformin for type II diabetes... 
Liver cancer | Type II diabetes mellitus | NAFLD | SIRT-3 | Sorafenib | Hepatocellular carcinoma | Metformin | NASH | Insulin | UNITED-STATES | CANCER-CELLS | RISK | SERUM | LIVER-DISEASE | TRENDS | IN-VITRO | INHIBITION | METABOLISM | ONCOLOGY | GROWTH | Immunohistochemistry | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Metformin - therapeutic use | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Liver Neoplasms - mortality | Metformin - adverse effects | Carcinoma, Hepatocellular - drug therapy | Drug Interactions | Time Factors | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Retrospective Studies | Liver Neoplasms - enzymology | Databases, Factual | Hypoglycemic Agents - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Carcinoma, Hepatocellular - enzymology | Diabetes Mellitus, Type 2 - diagnosis | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Diabetes Mellitus, Type 2 - mortality | Carcinoma, Hepatocellular - pathology | Italy | Aged | Sirtuin 3 - analysis | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin - therapeutic use | Antimitotic agents | Care and treatment | Patient outcomes | Hepatoma | Antineoplastic agents | Diabetes mellitus | Medical services | Paraffin | Patients | Survival | Chemotherapy | Diabetes | Metabolic disorders | Tumors | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9911, pp. 31 - 39
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9742, pp. 687 - 697
Summary Background Trastuzumab, a monoclonal antibody against human epidermal growth factor receptor 2 (HER2; also known as ERBB2), was investigated in... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | SUPPORTIVE CARE | MEDICINE, GENERAL & INTERNAL | METASTATIC BREAST-CANCER | ADVANCED ESOPHAGOGASTRIC CANCER | GENE AMPLIFICATION | 1ST-LINE THERAPY | HER2 | FLUOROURACIL | III TRIAL | PLUS | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Capecitabine | Humans | Middle Aged | Stomach Neoplasms - metabolism | Male | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Antibodies, Monoclonal, Humanized | Adenocarcinoma - metabolism | Fluorouracil - administration & dosage | Female | Drug Therapy, Combination | Receptor, ErbB-2 - biosynthesis | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Esophagogastric Junction | Antibodies, Monoclonal - administration & dosage | Survival Analysis | Aged | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Trastuzumab | Adenocarcinoma - mortality | Chemotherapy | Gastrointestinal cancer | Patient outcomes | Drug therapy, Combination | Drug therapy | Methods | Cancer | Voice recognition | Heart failure | Clinics | Heart attacks | Breast cancer | Blood pressure | Clinical medicine | Angina pectoris | Cancer therapies | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
CANCERS, ISSN 2072-6694, 04/2019, Volume 11, Issue 4, p. 578
Patients older than 75 years of age are usually excluded from metastatic colorectal cancer studies based on a combination chemotherapy containing oxaliplatin.... 
elderly patients | colorectal cancer | INTERNATIONAL-SOCIETY | BEVACIZUMAB | 1ST-LINE CHEMOTHERAPY | OLDER | PHASE-II | OPEN-LABEL | LIVER METASTASES | CAPECITABINE | doublet chemotherapy | ONCOLOGY | RECOMMENDATIONS | oxaliplatin | ELDERLY-PATIENTS
Journal Article
by Pererrone, Francesco and Daniele, Bruno and Battista Gaeta, Giovanni and Pignata, Sandro and Gallo, Ciro and Izzo, Francesco and Cuomo, Oreste and Capuano, Gaetano and Ruggiero, Giuseppe and Mazzanti, Roberto and Farinati, Fabio and Elba, Silvana and Daniele, Bruno and Pignata, Sandro and Cremona, Francesco and Parisi, Valerio and Fiore, Francesco and Vallone, Paolo and Di Palma, Massimo and Manno, Emilio and Militerno, Giuseppe and Budillon, Gabriele and Capuano, Gaetano and Cimino, Lucia and Pomponi, Domenico and Elio Adinolfi, Luigi and Ragone, Enrico and Ruggiero, Giuseppe and Utili, Riccardo and Arena, Umberto and Di Fiore, Giuseppe and Gentilini, Paolo and Mazzanti, Roberto and Farinati, Fabio and Rinaldi, Michela and Elba, Silvana and Coviello, Angelo and Giuseppe Manghisi, Onofrio and Crispino, Bernardino and Laviscio, Raffaele and Piai, Guido and Caporaso, Nicola and De Sio, Ilario and Belli, Giulio and Iannelli, Antonio and Luigi Santangelo, Mario and Ascione, Tiziana and Giusti, Giuseppe and D'Angelo, Valentina and Francica, Giampiero and Marone, Giampiero and Pasquale, Giuseppe and Piccinino, Felice and Stanzione, Maria and Raffaele Bianco, Angelo and De Placido, Sabino and Palmieri, Giovannella and D'Agostino, Luciano and Mattera, Daniele and Puzziello, Alessandro and Aiello, Antonino and Ferraú, Oscar and Antonietta Freni, Maria and Aloisio, Vincenza and Giorgio, Antonio and Perrotta, Anna and Calandra, Maria and Castellano, Luigi and Del Vecchio Blanco, Camillo and Castiglione, Fabiana and Mazzacca, Gabriele and Rispo, Antonio and Colurcio, Raffaele and Galanti, Bruno and Russo, Michele and Palmentieri, Bruno and Persico, Marcello and Felder, Martina and Zancanella, Laura and Belli, Mario and Colantuoni, Giuseppe and De Sena, Guido and Guardascione, Francesco and Petrelli, Gino and Lamorgese, Bruno and Manzione, Luigi and Pedicini, Tonino and D'Aprile, Modesto and Canc Liver Italian Program Investi and The Cancer of the Liver Italian Program(CLIP) Investigators
Hepatology, ISSN 0270-9139, 04/2000, Volume 31, Issue 4, pp. 840 - 845
Prognosis of patients with cirrhosis and hepatocellular carcinoma (HCC) depends on both residual liver function and tumor extension. The CLIP score includes... 
GASTROENTEROLOGY & HEPATOLOGY
Journal Article
Clinical Management Issues, ISSN 1973-4832, 10/2015, Volume 5, Issue 1S, pp. 11 - 16
The presented case regards a 63-year-old male patient who underwent radical surgery for an intermediate risk gastrointestinal stromal tumor (GIST) and... 
Relapse free survival | Imatinib mesilate | Primary GIST | Adjuvant therapy
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, pp. e66774 - e66774
Purpose: The potential impact of different SNPs of VEGF/VEGFR pathway on the clinical outcome of mCRC patients receiving bev-containing regimens has been... 
BIOMARKERS | LEUCOVORIN | CLINICAL-TRIAL DESIGNS | POLYMORPHISMS | MULTIDISCIPLINARY SCIENCES | PHASE-3 TRIAL | RESISTANCE | OXALIPLATIN | FLUOROURACIL | GENETIC-VARIATIONS | CHINESE POPULATION | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Colorectal Neoplasms - genetics | Humans | Middle Aged | Neovascularization, Pathologic | Male | Vascular Endothelial Growth Factor A - genetics | Bevacizumab | Vascular Endothelial Growth Factor Receptor-2 - genetics | Neoplasm Metastasis | Fluorouracil - administration & dosage | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Camptothecin - administration & dosage | Adenocarcinoma - genetics | Retrospective Studies | Drug Therapy, Combination | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Gene Expression | Antibodies, Monoclonal, Humanized - therapeutic use | Colorectal Neoplasms - blood supply | Treatment Outcome | Adenocarcinoma - drug therapy | Sequence Analysis, DNA | Adenocarcinoma - blood supply | Survival Analysis | Aged | Polymorphism, Single Nucleotide | Adenocarcinoma - mortality | Care and treatment | Vascular endothelial growth factor | Analysis | Risk factors | Colorectal cancer | Impact prediction | Colorectal carcinoma | Clinical trials | Oncology | Single-nucleotide polymorphism | Metastasis | Cancer therapies | Patients | Metastases | Vascular endothelial growth factor receptors | Angiogenesis | Experimental design | Peripheral blood | Biomarkers | Population | Mathematical models | Deoxyribonucleic acid--DNA | Cancer | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Journal Article